MVA-BN Brachyury TRICOM vaccine

N/A

Report date: 2026/04/06 20:01:48

Base Information

Drug NameMVA-BN Brachyury TRICOM vaccine
Drug Alias NameMVA-brachyury-TRICOMBrachyury/TRICOMMVA-BN-Brachyury vaccineBN-Brachyury
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Recombinant vector vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMetastatic breast cancerSolid tumoursNeoplasm Metastasis +[11] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNational Cancer InstituteBavarian Nordic A/S
China Registration ClassN/A

Develop Information

Active CompaniesNational Cancer InstituteBavarian Nordic A/S
Inactive CompaniesN/A
Active IndicationsSolid tumoursProstatic Neoplasms, Castration-ResistantProstatic Neoplasms +[4] 
Inactive IndicationsMetastatic breast cancerNeoplasm MetastasisLung Neoplasms +[7] 

Other Information

ATC CodeN/A
Related LinksN/A